Keith Berelowitz patientRx Limited
Keith has dedicated over 20 years to the field of clinical research, specialising in patient engagement and retention. As the founder of patientRx Ltd., he is committed to making clinical trials more patient-centric whilst ensuring trials meet scientific, operational and commercial objectives. Working predominantly with biotech in the US, UK and Europe, Keith also supports companies acting as a strategic advisor and board member for companies in the biopharma health-tech supply chain.
In his previous leadership role he led effective patient recruitment strategies whilst serving as Director of Operations and subsequently Commercial Director. His commitment to ethical research is evident in his role as Chair of the Fulham Research Ethics Committee.
Throughout his career, Keith has consistently shared his insights by authoring and presenting on patient recruitment and engagement. He’s driven by a desire to optimise clinical trials through patient-centric strategies, ensuring effective and ethical research solutions for all stakeholders – biotech and pharmaceutical companies, patients, and researchers alike.
Keith is currently focused on the commercialisation of multi-stakeholder platform, driven by lived experience, proven methodology and AI assisted technology to support better patient engagement and retention in clinical research.